File Download

There are no files associated with this item.

Supplementary

Conference Paper: Ascending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial

TitleAscending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial
Authors
Issue Date2019
Citation
Journal of hepatology : the journal of the European Association for the Study of the Liver, v. 701, p. E47-48 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/275323

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorChen, CY-
dc.contributor.authorLiu, CJ-
dc.contributor.authoret al, .-
dc.date.accessioned2019-09-10T02:40:14Z-
dc.date.available2019-09-10T02:40:14Z-
dc.date.issued2019-
dc.identifier.citationJournal of hepatology : the journal of the European Association for the Study of the Liver, v. 701, p. E47-48-
dc.identifier.urihttp://hdl.handle.net/10722/275323-
dc.languageeng-
dc.relation.ispartofJournal of hepatology : the journal of the European Association for the Study of the Liver-
dc.titleAscending dose cohort study of inarigivir - A novel RIG I agonist in chronic HBV patients: Final results of the ACHIEVE trial-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.hkuros304551-
dc.identifier.volume701-
dc.identifier.spageE47-
dc.identifier.epage48-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats